David Mazer

Research Synopsis

Dr. Mazer's clinical and research interests include cardiac anesthesia and critical care. His basic science program has focused on perioperative blood conservation, cardiac physiology and metabolism and perioperative organ protection. He is also actively engaged in translational research as an investigator in both clinical studies and randomized controlled trials in these areas. Dr. Mazer is the co-founder of the CardioLink platform of clinical trials in patients with cardiovascular disease. He has co-authored over 200 peer-reviewed publications, including practice guidelines and position statements related to perioperative transfusion and hemostasis from the Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists and the Canadian Cardiovascular Society. He was a lead anesthesia investigator in the BART trial and is currently the principal investigator for TRICS III and TRICS IV, a global study of transfusion triggers in cardiac surgery.